SecBot SecBot

HSCS

HeartSciences Inc.
Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies· Inc. TX· CIK 0001468492 Healthcare & Medical Devices
$3.13 −0.01 (−0.32%)
Oct 26 4:00 PM ET · prev $3.14
Market cap
$15.4M
Nano cap
Median target
$12.00
+283% · range $12.00–12.00
1 year
−3.4%
from $3.24 · Oct 27
30 days
−29.3%
from $4.43
52-week range
$1.67–5.20
−40% from high · low May 29
Avg volume 20D
232.0K
Oct 5 spike 2.14M
Short interest
27.9K
≈0.6% of shares · −29.9%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
49
analyzed by SecBot
SecBot read MIXED 43 reports · 90 days
Balance 4 bearish · 3 bullish · 4 mixed · 32 neutral oldest → newest, height = score
Avg score ·High conf. 21/43
Strongest BEARISH HeartSciences Inc. (HSCS) is seeking shareholder approval at a November 19, 2026 special meeting for a…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.695 → −$0.620 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersCOVERING

    Short interest −29.9% to 27.9K shares. 1.0 days to cover, ≈0.6% of shares.

  • TrendDOWNTREND

    11% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
OSAIC HOLDINGS, INC.DOUBLED650$1.6K
GEODE CAPITAL MANAGEMENT, LLCDOUBLED26,928$83.2K
BANK OF AMERICA CORP /DE/ADD26$80.00
Federation des caisses Desjardins du QuebecADD700$2.4K
BANK OF AMERICA CORP /DE/ADD19$66.00
UBS Group AGDOUBLED2,625$7.4K
UBS Group AGADD1,305$5.0K
BANK OF AMERICA CORP /DE/ADD7$34.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2026
12-month targets · 1 analysts

Price is below the lowest target. Median implies +283%.Targets as of Oct 26, 2026.

Recent actions
DateFirmActionRating
Mar 24, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy
Dec 22, 2025Ascendiant Capital
MAINTAIN
MAINTAINBuy
Oct 1, 2025Ascendiant Capital
MAINTAIN
MAINTAINBuy
Mar 18, 2025Ascendiant Capital
MAINTAIN
MAINTAINBuy
Dec 18, 2024Maxim Group
REITERATE
REITERATEBuy
Sep 23, 2024Ascendiant Capital
REITERATE
REITERATEBuy

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Jul 7, 2026
Watson Danielle
See Remarks
AWARD25,000 sh
Jun 22, 2026
Simpson Andrew
See Remarks
AWARD425,000 sh

Earnings setup

Estimates
−$0.62
EPS estimate, this quarter
+11%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.62-$0.62–-$0.62+4.6%$0.00
Next Q-$0.61-$0.61–-$0.61+7.6%$5.0K
Current FY-$2.46-$2.46–-$2.46+6.1%$17.1K
Next FY-$1.75-$1.75–-$1.75+5.9%$3.1M
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 15, 2026
Earnings
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform anchored in Zcash, continues to progress, with…
Aug 12, 2026
Listing
Listing Status: HSCS — Deficient (was Normal)
HeartSciences Inc. - Common Stock | Nasdaq Financial Status Indicator N → D
Jul 29, 2026
Earnings
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
Company believes proposed Fortitude Mining Holdings business combination represents a significant value creation opportunity for the Company’s…
Jul 23, 2026
Earnings
HeartSciences Files Its Fiscal 2026 Annual Report on Form 10-K
Company believes proposed Fortitude merger represents a significant opportunity for the Company’s shareholders; preliminary proxy statement in…
Jul 22, 2026
Earnings date
HSCS Q4 2026 Earnings After Market Close — 2026-07-22

Short side

FINRA· Sep 30, 2026
27,931
shares short
-29.9%
vs prior settlement
1.0
days to cover
≈0.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 26, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Oct 23, 2026 SEC
CEO Andrew Simpson filed an amended Schedule 13D disclosing unchanged beneficial ownership of 403,739 shares (7.5% of…
SC 13D/A — Impact 3/10
Oct 21, 2026 SEC
HeartSciences Inc. filed a DEFA14A providing additional soliciting materials in connection with its proposed all-stock…
DEFA14A — Impact 5/10
Sep 15, 2026 Earnings
HeartSciences Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
Proposed business combination with Fortitude, a vertically-integrated digital asset mining platform
Jul 7, 2026 Insider
Watson Danielle was granted 25,000 shares
See Remarks
Jun 30, 2026 Inst.
OSAIC HOLDINGS, INC. — DOUBLED
650 shares ($1.6K)
Jun 22, 2026 Insider
Simpson Andrew was granted 425,000 shares
See Remarks
Mar 16, 2026 Press
HeartSciences Inc. reported financial results for its fiscal third quarter ended January 31, 2026, along with a…
Impact 3/10

SecBot reports

49 filings · 1 press release · 3 bullish · 4 bearish · 5 mixed · 37 neutral
All HSCS filing & press-release reports (50)